Lead Sheet

Real-time Expert BD Intelligence

CROs, CMOs and CDMOs worldwide depend on the PharmSource Lead Sheet for fresh leads, up-to-date contact information and reliable market intelligence. Quickly scout well-targeted new business opportunities. Learn more

Strategic Advantage

Proprietary Global Sourcing Intelligence in an Instant

Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more

Blog

Bio/Pharma CapEx Trends: Sponsor Spending on In-House Capacity Trounces Outsourcing

Investment in captive manufacturing capacity by bio/pharma companies is an indicator of the industry’s intentions with respect to outsourcing. Based on recent capital expenditure trends, it’s clear that bio/pharma companies would rather…

Our Thinking

Outlook for the CMO Industry

The outlook for the contract manufacturing industry is being shaped by several significant trends. The well-financed pipeline makes the near term outlook favorable, but much depends on the number of new approvals for small and mid-size companies. Injectables CMOs should…

Market Intelligence

Demand and Supply for Contract Manufacturing of Conventional Injectable Drugs Through 2019

This extensive study estimates the demand for contract injectable manufacturing through 2019 and analyzes the supply and demand relationships for these services. Accompanied by a report on the cytotoxic injectable drug outlook, this expert report covers…

Trend Reports

Not So NICE: How Market Access Schemes Impact the CMO Sector

This PharmSource Trend Report addresses how European drug-rationing policies could affect pharmaceutical manufacturing profitability – and future operations – in the EU, US and elsewhere.

As economic austerity forces Europe’s state-funded health-care systems to limit patient access to just…